2020, Número 4
<< Anterior Siguiente >>
Dermatología Cosmética, Médica y Quirúrgica 2020; 18 (4)
Placas de psoriasis sobre piel con vitiligo: reporte de dos casos
Ochoa RLA, Ríos BER, Ríos TJJ, Muñoz MR, Gaxiola ÁEA, Velarde FJS
Idioma: Ingles.
Referencias bibliográficas: 16
Paginas: 339-341
Archivo PDF: 319.65 Kb.
RESUMEN
La psoriasis y el vitiligo son enfermedades dermatológicas comunes
que comparten una patogénesis autoinmune. Si bien su
concomitancia es ocasionalmente observada en la práctica clínica,
el desarrollo de placa psoriásica sobre áreas de vitiligo es
rara. Aquí se reporta el anteriormente mencionado fenómeno
en dos mujeres del noroeste de México y se explica sobre su
posible causa.
REFERENCIAS (EN ESTE ARTÍCULO)
Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE, Vitiligo Working Group. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol 2017;77:1-13.
Park JM, Kim HJ, Bae BG, Park YK. A case of concurrent vitiligo and psoriasis. Ann Dermatol. 2009;21:330-3.
Gudjonsson JE, Johnston A, Sigmundsdottir H, Valdimarsson H. Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 2004;135:1-8.
De Sica AB, Wakelin S. Psoriasis vulgaris confined to vitiligo patches and occurring contemporaneously in the same patient. Clin Exp Dermatol 2004;29:434-5.
Rodríguez-Martín M, Sáez-Rodríguez M, Carnerero-Rodríguez A, et al. Coincidental presentation of vitiligo and psoriasis in a patient with polyglandular autoimmune syndrome. Clin Exp Dermatol 2007;32:453-4.
Sharquie KE, Salman HA, Yaseen AK. Psoriasis and vitiligo are close relatives. Clin Cosmet Investig Dermatol 2017;10:341-5.
Sawchuk M, Spano F, Loo WJ, Guenther L. The coexistence of psoriasis and vitiligo: a review. J Cutan Med Surg 2012;16:300-5.
Berger TG, Kiesewetter F, Maczek C, et al. Psoriasis confined strictly to vitiligo areas – a Koebner-like phenomenon? J Eur Acad Dermatol Venereol 2006;20:178-83.
Zhu KJ, Lv YM, Yin XY, et al. Psoriasis regression analysis of MHC loci identifies shared genetic variants with vitiligo. PLoS One 2011;6:e23089.
Mancheno Valencia A, Rosas Manzano A, Toussaint Caire S, Lacy Niebla RM. Coexistence of vitiligo and psoriasis, case series and etiopathogenic perspectives. Rev Argent Dermatol 2015;96:80-91.
Webb KC, Tung R, Winterfield LS, et al. Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo. Br J Dermatol 2015;173:641-50.
Prinz JC. Melanocytes: Target cells of an HLA-C*06:02-restricted autoimmune response in psoriasis. J Invest Dermatol 2017;137:2053-8.
Arakawa A, Siewert K, Stöhr J, et al. Melanocyte antigen triggers autoimmunity in human psoriasis. J Exp Med 2015;212:2203-12.
Chen HW, Tsai JP, Yao TY, Hsieh CL, Chen IH, Liu SJ. TGF-β and IL-21 cooperatively stimulate activated cd8+ T cells to differenciate into Tc17 cells. Immunol Lett 2016;174:23-7.
Sushama S, Dixit N, Gautam RK, Arora P, Khurana A, Anubhuti A. Cytokine profile (IL-2, IL-6, IL-17, IL-22, and tnf-α) in vitiligo-New insight into pathogenesis of disease. J Cosmet Dermatol 2019;18(1):337-41.
Ceovic R, Mance M, Bukvic Mokos Z, Svetec M, Kostovic K, Stulhofer Buzina D. Psoriasis: female skin changes in various hormonal stages throughout life—puberty, pregnancy and menopause. Biomed Res Int 2013;2013:571912.